Stay updated with breaking news from Abcellera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript February 20, 2024 AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. AbCellera Biologics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. […] ....
After a stretch of sluggish investment, two of Canada’s largest tech ecosystems saw a resurgence in venture funding in the second quarter of 2023. ....